导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.76% | 934/1050 |
| 近一周 | -3.21% | 942/1104 |
| 近一月 | -4.66% | 735/1103 |
| 近一季 | -5.65% | 501/1092 |
| 近半年 | -16.26% | 932/1070 |
| 近一年 | -18.87% | 886/1018 |
| 近两年 | 6.89% | 853/926 |
| 近三年 | -11.86% | 739/834 |
| 成立以来 | 27.14% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.94% 814/1070 |
-5.61% 814/1101 |
- - |
- - |
| 2025 | 14.00% 773/1065 |
4.37% 452/1014 |
-1.30% 798/1038 |
17.85% 668/1050 |
-6.09% 745/1065 |
| 2024 | 0.91% 555/1011 |
-0.54% 343/960 |
-2.64% 476/983 |
11.34% 517/991 |
-6.40% 752/1011 |
| 2023 | -15.26% 531/952 |
4.61% 348/880 |
-8.82% 725/895 |
-4.49% 268/915 |
-6.98% 671/952 |
| 2022 | -18.69% 285/867 |
-20.44% 538/773 |
17.74% 58/806 |
-12.14% 400/845 |
-1.21% 498/867 |
| 2021 | -11.63% 496/740 |
-6.39% 396/580 |
13.34% 278/659 |
-18.94% 643/704 |
2.75% 316/740 |
| 2020 | 75.84% 111/554 |
-2.79% 230/419 |
31.45% 107/466 |
14.80% 145/517 |
19.87% 122/554 |
| 2019 | - - |
- - |
- - |
- - |
2.08% 379/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇添富内需增长股票A VS. 东吴新产业精选股票A(580008) |